Capital Expenditures for West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's current capital expenditures (TTM) is $257.30M USD. Capital expenditures (CapEx) are cash outlays for property, plant, and equipment and other long-lived productive assets — reported on the cash flow statement under investing activities. CapEx funds future capacity (factories, data centers, software, machinery), so rising spend can signal investment in growth, while heavy CapEx reduces free cash flow available to shareholders. We display CapEx as a positive amount (the absolute cash outflow); compare with revenue to gauge capital intensity and with total assets for the asset-base context.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
Currently viewingCapital ExpendituresSwitch metric
Latest period
$257.30M
YoY change
-24.2%
5Y CAGR
+10.4%
Peak year (2024)
$377.00M
Cumulative capital expenditures
$4.16B
CapEx history chart for West Pharmaceutical Services (WST) from 1989 to 2025
CapEx history table for West Pharmaceutical Services (WST) from 1989 to 2025
| Fiscal year | Period ended | Reported | Capital Expenditures | YoY |
|---|---|---|---|---|
| 2025 | $285.90M | -24.2% | ||
| 2024 | $377.00M | +4.1% | ||
| 2023 | $362.00M | +27.2% | ||
| 2022 | $284.60M | +12.3% | ||
| 2021 | $253.40M | +45.3% | ||
| 2020 | $174.40M | +38.0% | ||
| 2019 | $126.40M | +20.7% | ||
| 2018 | $104.70M | -20.0% | ||
| 2017 | $130.80M | -23.1% | ||
| 2016 | $170.20M | +29.3% | ||
| 2015 | $131.60M | +17.4% | ||
| 2014 | $112.10M | -28.0% | ||
| 2013 | $155.80M | +18.0% | ||
| 2012 | $132.00M | +36.4% | ||
| 2011 | $96.80M | +31.2% | ||
| 2010 | $73.80M | -31.5% | ||
| 2009 | $107.80M | -22.5% | ||
| 2008 | $139.10M | +7.5% | ||
| 2007 | $129.40M | +43.3% | ||
| 2006 | $90.30M | +66.9% | ||
| 2005 | $54.10M | -5.7% | ||
| 2004 | $57.40M | -5.6% | ||
| 2003 | $60.80M | +61.3% | ||
| 2002 | $37.70M | -14.5% | ||
| 2001 | $44.10M | -23.0% | ||
| 2000 | $57.30M | -9.6% | ||
| 1999 | $63.40M | -17.3% | ||
| 1998 | $76.70M | +123.0% | ||
| 1997 | $34.40M | +8.5% | ||
| 1996 | $31.70M | +1.3% | ||
| 1995 | $31.30M | +15.5% | ||
| 1994 | $27.10M | -19.1% | ||
| 1993 | $33.50M | +49.6% | ||
| 1992 | $22.40M | -12.2% | ||
| 1991 | $25.50M | -23.2% | ||
| 1990 | $33.20M | -3.2% | ||
| 1989 | $34.30M | — |
CapEx values are taken from West Pharmaceutical Services's reported cash flow statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, West Pharmaceutical Services (WST) reported capital expenditures of $285.90M – declined 24.2% year-over-year.
West Pharmaceutical Services capital expenditures has recorded the values shown across consecutive periods, with a +10.4% compound annual growth rate over 2020–2025 (5 years).
Between 2024 and 2025, West Pharmaceutical Services capital expenditures declined 24.2%, falling from $377.00M to $285.90M.
$377.00M stands as the all-time-high annual capital expenditures, posted in 2024, against a low of $22.40M during 1992.
West Pharmaceutical Services (WST) sits 9th of 8 Healthcare peers we track on this metric, against a peer median of $3.87B.
West Pharmaceutical Services Capital Expenditures by Year
West Pharmaceutical Services Capital Expenditures 2025: $285.90M
West Pharmaceutical Services capital expenditures in 2025 was $285.90M, declined 24.2% below 2024.
West Pharmaceutical Services Capital Expenditures 2024: $377.00M
West Pharmaceutical Services capital expenditures in 2024 was $377.00M, edged up 4.1% from 2023. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Capital Expenditures 2023: $362.00M
West Pharmaceutical Services capital expenditures in 2023 was $362.00M, grew 27.2% from 2022.
West Pharmaceutical Services Capital Expenditures 2022: $284.60M
West Pharmaceutical Services capital expenditures in 2022 was $284.60M, grew 12.3% from 2021.
West Pharmaceutical Services Capital Expenditures 2021: $253.40M
West Pharmaceutical Services capital expenditures in 2021 was $253.40M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers — CapEx
Companies in the same sector as West Pharmaceutical Services, ranked by their latest capital expenditures.
| Company | Capital Expenditures | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $90.11B | Healthcare |
| Eli Lilly and Company (LLY) | $7.84B | Healthcare |
| Johnson & Johnson (JNJ) | $4.83B | Healthcare |
| Merck & Co., Inc. (MRK) | $4.11B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $3.62B | Healthcare |
| AstraZeneca PLC (AZN) | $2.81B | Healthcare |
| Amgen Inc. (AMGN) | $1.86B | Healthcare |
| AbbVie Inc. (ABBV) | $1.21B | Healthcare |
Frequently asked questions
What is West Pharmaceutical Services's capital expenditures?
- Latest reported capital expenditures for West Pharmaceutical Services (WST) is $257.30M (period ending March 31, 2026).
How has West Pharmaceutical Services capital expenditures changed year-over-year?
- West Pharmaceutical Services (WST) capital expenditures changed -24.2% year-over-year on the latest annual filing.
What is the long-term growth rate of West Pharmaceutical Services capital expenditures?
- West Pharmaceutical Services (WST) capital expenditures compound annual growth rate is +10.4% over the most recent 5 years available.
When did West Pharmaceutical Services capital expenditures hit its highest annual value?
- West Pharmaceutical Services capital expenditures reached its highest annual value of $377.00M in 2024.
What was West Pharmaceutical Services capital expenditures in 2024?
- West Pharmaceutical Services (WST) capital expenditures in 2024 was $377.00M.
What was West Pharmaceutical Services capital expenditures in 2025?
- West Pharmaceutical Services (WST) capital expenditures in 2025 was $285.90M.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
WST Overview
Company profile, financial tools, and key metrics
WST Revenue Counter
Earns $102.12 every second. See per minute, hour, and day.
WST Earnings Counter
Earns $17.21 per second net profit. See per minute, hour, and day.
WST Economic Scale
Exceeds Belize's GDP. Compare with world economies.
WST What If Invested
What if you had invested $1,000? See historical returns from any date.
WST How It Makes Money
Discover visual breakdown of $3.22B in revenue — where it comes from and where it goes.
WST Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
WST Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
WST Daily Price Character
Steady · 44.8% historical win rate (green days). Streaks & record days.
WST Buybacks
1.65% TTM buyback yield. Shareholder yield & SBC comparison.
WST Stock Split History
4 splits on record. Dates, ratios, and cumulative multiple.
WST Dividend Profile
Yield: 0.29%. Safety: 6/8. See full history.
WST Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
WST Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.